BCM-95® (CURCUGREEN®), 07 Aug 2021
Saeede Saadati, Azita Hekmatdoost, Behzad Hatami, Asieh Mansour, Zahra Yari, Mehdi Hedayati, Amir Sadeghi
Aim: The aim of this study was to examine the effects of curcumin supplementation on hepatic fibrosis using different fibrosis
Background: Nonalcoholic fatty liver disease (NAFLD) may progress to hepatic fibrosis. Detection of hepatic fibrosis should be measured by liver biopsy, which is an invasive method. Thus, some non-invasive methods are suggested.
Methods: Hepatic fibrosis was evaluated in forty-six patients with NAFLD before and three months after supplementation with 1.5 gram curcumin or placebo. Methods of assessments included fibroscan, and calculating non-invasive marker panel including FIB-4 (Fibrosis4), NFS (NAFLD fibrosis score), APRI (AST (Aspartate aminotransferase) Platelet Ratio Index), and BARD (body mass index, AST/ALT (Alanine aminotransferase ratio, diabetes).
Results: Fibrosis score was reduced significantly after curcumin supplementation using fibroscan (p<0.01), FIB-4 (p<0.05) and APRI (p<0.05) tests, while fibrosis score did not change significantly using BARD and NFS methods (p>0.05).
Conclusion: Our results revealed that fibroscan, FIB-4, and APRI are similar in assessment of hepatic fibrosis changes after curcumin
supplementation. Future studies with higher sample sizes are needed to confirm these results.
Let’s collaborate to refine your ideas or built from scratch
Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown...Read More